Key Record Dates
ClinicalTrials.gov Identifier: | NCT06007690 |
---|---|
Brief Title: | A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (CoMpass) |
First Submitted : | August 17, 2023 |
First Submitted that Met QC Criteria : | August 17, 2023 |
First Posted : | August 23, 2023 |
Last Update Submitted that Met QC Criteria : | May 3, 2024 |
Last Update Posted : | May 6, 2024 |